DT&CRO Says It Will Digitize Non-Clinical Toxicity Assessment, Building 'AI Pathology' Early Next Year
Predicted impact: Low· Actual: −9.7% vs sector, volume 0.6× normal (5 trading days)
Plan to digitize toxicity testing; no revenue or size figures given.